Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer

Condition:   Metastatic or Non-driver Gene Mutation Non-small Cell Lung Cancer Intervention:   Drug: Sintilimab Combined With Docetaxel Monotherapy Sponsor:   Yongchang Zhang Recruiting

Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials